VDUP1 mediates nuclear export of HIF1α via CRM1-dependent pathway

[1]  L. Poellinger,et al.  Cell-Type-Specific Regulation of Degradation of Hypoxia-Inducible Factor 1α: Role of Subcellular Compartmentalization , 2006, Molecular and Cellular Biology.

[2]  Margaret Ashcroft,et al.  Negative and positive regulation of HIF-1: a complex network. , 2005, Biochimica et biophysica acta.

[3]  V. Nizet,et al.  HIF-1alpha expression regulates the bactericidal capacity of phagocytes. , 2005, The Journal of clinical investigation.

[4]  Hiroshi Nakamura,et al.  TCR Engagement Increases Hypoxia-Inducible Factor-1α Protein Synthesis via Rapamycin-Sensitive Pathway under Hypoxic Conditions in Human Peripheral T Cells1 , 2005, The Journal of Immunology.

[5]  Chae Young Hwang,et al.  Tumor suppressor VDUP1 increases p27(kip1) stability by inhibiting JAB1. , 2005, Cancer research.

[6]  K. Song,et al.  VDUP1 is required for the development of natural killer cells. , 2005, Immunity.

[7]  J. Pouysségur,et al.  HIF-1: master and commander of the hypoxic world. A pharmacological approach to its regulation by siRNAs. , 2004, Biochemical pharmacology.

[8]  Y. Ishii,et al.  Importin α1 (Rch1) Mediates Nuclear Translocation of Thioredoxin-binding Protein-2/Vitamin D3-up-regulated Protein 1* , 2004, Journal of Biological Chemistry.

[9]  M. Rosenfeld,et al.  Nuclear receptor coregulators: their modification codes and regulatory mechanism by translocation. , 2004, Biochemical and biophysical research communications.

[10]  L. Gunaratnam,et al.  HIF activation by pH-dependent nucleolar sequestration of VHL , 2004, Nature Cell Biology.

[11]  Søren Brunak,et al.  Analysis and prediction of leucine-rich nuclear export signals. , 2004, Protein engineering, design & selection : PEDS.

[12]  Christopher J. Schofield,et al.  Oxygen sensing by HIF hydroxylases , 2004, Nature Reviews Molecular Cell Biology.

[13]  J. Meller,et al.  von Hippel-Lindau tumor suppressor: not only HIF's executioner. , 2004, Trends in molecular medicine.

[14]  Stefan Schüchner,et al.  Nuclear–cytoplasmic shuttling of BARD1 contributes to its proapoptotic activity and is regulated by dimerization with BRCA1 , 2004, Oncogene.

[15]  J. Massagué,et al.  Nucleocytoplasmic shuttling of signal transducers , 2004, Nature Reviews Molecular Cell Biology.

[16]  Kyu-Won Kim,et al.  Hypoxia-inducible factor (HIF-1)α: its protein stability and biological functions , 2004, Experimental & Molecular Medicine.

[17]  L. Poellinger,et al.  HIF-1 and hypoxic response: the plot thickens. , 2004, Current opinion in genetics & development.

[18]  G. Semenza.  Targeting HIF-1 for cancer therapy , 2003, Nature Reviews Cancer.

[19]  Jun Ho Jeon,et al.  VDUP1 upregulated by TGF-β1 and 1,25-dihydorxyvitamin D3 inhibits tumor cell growth by blocking cell-cycle progression , 2003, Oncogene.

[20]  B. Brüne,et al.  Tumor Necrosis Factor- (cid:1) Causes Accumulation of a Ubiquitinated Form of Hypoxia Inducible Factor-1 (cid:1) through a Nuclear Factor- (cid:2) B–Dependent Pathway , 2022 .

[21]  L. Neckers,et al.  Hypoxia-inducible factor induction by tumour necrosis factor in normoxic cells requires receptor-interacting protein-dependent nuclear factor kappa B activation. , 2003, The Biochemical journal.

[22]  G. Semenza,et al.  Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. , 2003, Cancer research.

[23]  D. Frings,et al.  Butyrate impairs intestinal tumor cell-induced angiogenesis by inhibiting HIF-1α nuclear translocation , 2003 .

[24]  L. Freedman,et al.  Melanoma metastasis suppression by chromosome 6: evidence for a pathway regulated by CRSP3 and TXNIP. , 2003, Cancer research.

[25]  G. Powis,et al.  The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis. , 2002, Cancer research.

[26]  Stephen Lee,et al.  Oxygen-Dependent Ubiquitination and Degradation of Hypoxia-Inducible Factor Requires Nuclear-Cytoplasmic Trafficking of the von Hippel-Lindau Tumor Suppressor Protein , 2002, Molecular and Cellular Biology.

[27]  Michael I. Wilson,et al.  Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation , 2001, Science.

[28]  Stephen Lee,et al.  Role of Exon 2-encoded β-Domain of the von Hippel-Lindau Tumor Suppressor Protein* , 2001, The Journal of Biological Chemistry.

[29]  L. Poellinger,et al.  Mechanism of regulation of the hypoxia‐inducible factor‐1α by the von Hippel‐Lindau tumor suppressor protein , 2000, The EMBO journal.

[30]  H. Um,et al.  Vitamin D3 Up-Regulated Protein 1 Mediates Oxidative Stress Via Suppressing the Thioredoxin Function1 , 2000, The Journal of Immunology.

[31]  Stephen Lee,et al.  Ran-mediated Nuclear Export of the von Hippel-Lindau Tumor Suppressor Protein Occurs Independently of Its Assembly with Cullin-2* , 2000, The Journal of Biological Chemistry.

[32]  C. Wykoff,et al.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.

[33]  L. Poellinger,et al.  Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of theCBP/p300 coactivator by the hypoxia‐induciblefactor‐1α , 1998, The EMBO journal.

[34]  M. Yanagida,et al.  Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. , 1998, Experimental cell research.

[35]  R. Klausner,et al.  Nuclear/cytoplasmic localization of the von Hippel-Lindau tumor suppressor gene product is determined by cell density. , 1996, Proceedings of the National Academy of Sciences of the United States of America.